Evidence map›Paper›PMID 35891533›Full record

ArticleViruses2022

Antiviral Effect of hBD-3 and LL-37 during Human Primary Keratinocyte Infection with West Nile Virus.

Céline Chessa, Charles Bodet, Clément Jousselin, Andy Larivière, Alexia Damour, Julien Garnier, Nicolas Lévêque, Magali Garcia

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Update on antimicrobial peptides: key elements inThe Journal of general virology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Céline ChessaLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Charles BodetLaboratoire Inflammation, Tissus Epithéliaux et Cytokines, LITEC, UR 15560, Université de Poitiers, Pôle Biologie Santé, Bâtiment B36, 1, Rue Georges Bonnet, TSA 51106, CEDEX 09, 86073 Poitiers, France.ORCID 0000-0002-8016-0324
Clément JousselinLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Andy LarivièreLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Alexia DamourLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Julien GarnierQima Bioalternatives, 1 Rue des Plantes, 86160 Gençay, France.ORCID 0000-0001-5196-3999
Nicolas LévêqueLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Magali GarciaLaboratoire de Virologie, CHU de Poitiers, 2, Rue de la Milétrie, CS 90577, 86000 Poitiers, France.
Université de Poitiers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

West Nile virus (WNV) is an emerging flavivirus transmitted through mosquito bites and responsible for a wide range of clinical manifestations. Following their inoculation within the skin, flaviviruses replicate in keratinocytes of the epidermis, inducing an innate immune response including the production of antimicrobial peptides (AMPs). Among them, the cathelicidin LL-37 and the human beta-defensin (hBD)-3 are known for their antimicrobial and immunomodulatory properties. We assessed their role during WNV infection of human primary keratinocytes. LL-37 reduced the viral load in the supernatant of infected keratinocytes and of the titer of a viral inoculum incubated in the presence of the peptide, suggesting a direct antiviral effect of this AMP. Conversely, WNV replication was not inhibited by hBD-3. The two peptides then demonstrated immunomodulatory properties whether in the context of keratinocyte stimulation by poly(I:C) or infection by WNV, but not alone. This study demonstrates the immunostimulatory properties of these two skin AMPs at the initial site of WNV replication and the ability of LL-37 to directly inactivate West Nile viral infectious particles. The results provide new information on the multiple functions of these two peptides and underline the potential of AMPs as new antiviral strategies in the fight against flaviviral infections.

Indexed as

beta-DefensinsCathelicidinsKeratinocytesWest Nile FeverAntiviral Restriction FactorsHumansWest Nile virusAntiviral Restriction Factorsbeta-DefensinsCAMP protein, humanCathelicidinsantimicrobial peptidesantiviralflavivirushBD-3immunomodulationkeratinocytesLL-37West Nile virus

Identifiers

PMID35891533
PMCPMC9319560
OpenAlexW4285733189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.